Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129250) titled 'A Real-World Study on the Efficacy and Safety of Isavuconazole in the Treatment of Invasive Mold Disease in Children' on Aug. 1.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Beijing Childrens Hospital,Capital Medical University

Condition: Invasive Mold Disease

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-01

Target Sample Size: Isavuconazole group:60;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=335825

Published by HT Digital Content Services with permission from Health Daily Digest....